Article info
PDFNeurodegeneration
Original research
Value of systematic genetic screening of patients with amyotrophic lateral sclerosis
- Correspondence to Professor Pamela J Shaw, Sheffield Institute for Translational Neuroscience, The University of Sheffield, Sheffield, Sheffield, UK; pamela.shaw{at}sheffield.ac.uk
Citation
Value of systematic genetic screening of patients with amyotrophic lateral sclerosis
Publication history
- Received September 1, 2020
- Revised November 15, 2020
- Accepted November 25, 2020
- First published February 14, 2021.
Online issue publication
April 15, 2021
Article Versions
- Previous version (14 February 2021).
- Previous version (16 February 2021).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:http://creativecommons.org/licenses/by-nc/4.0/.